Saturday, November 30, 2024 9:19:57 AM
Give it up WeeZuhl.
You are so negative, I cannot believe you own shares (but you claim you do).
Your personal vendetta does nothing but display negative sentiment towards the company which happens to be doing very nicely. The problem I have is your statements of negativity are also read by potential investors who think the company is a complete fraud which is not the case. Perhaps we would do better if you refrained from this unproductive information about something that happened years ago and is not relevant either to today's business or any potential buyout.
I'll go ahead and respond to this, Yankee001, since you were able to express a rational opinion without resorting to personal attacks. Nonetheless, I disagree with everything you say. Feel free to read my post history, and you will find many positive comments from me about this company. When I have something positive to say that nobody else has already said, I do, and if you're really interested in the truth, they're all there for you to read and enjoy. Everything is true- both positive and negative, and how people interpret facts is up to them, not me. If I post a fact about Elite history and it causes someone to believe there was fraud involved, then that has a lot more to do with the behavior of the company than it does with me. Bless your heart for believing I have anything to do with the share price, but I think that is naive. There is a person who does have a very strong effect on the share price, and it seems you believe he is above comment and criticism. IMO, he is an extremely mediocre CEO. He might have been great, but he was never able to fully integrate his fiduciary duties as CEO of a public company. He never learned how to put the interests of Elite shareholders ahead of Mikah and his own personal interests. When I report the accurate history of Hakim as CEO, that is what I'm showing you, and you are welcome to accept it or reject it, doesn't matter to me. Yes it is finally "doing nicely," but it isn't doing anything it couldn't have done five years ago under the leadership of virtually anyone else whose primary motivation was Elite shareholders and not to become a billionaire on the side.
I don't owe Hakim anything beyond the extremely generous salary I have paid him. I don't owe him any praise, and I don't owe him special thanks on Thanksgiving. Where does this groupthink idea come from? This concept that every member of a group has to have the same warm and fuzzy feelings about dear leader-- what are the origins of this and who benefits? Who benefits when we try to make this a discussion about WeeZuhl and not about Hakim? I state facts, and I clearly explain how I interpret them. Feel free to agree or disagree. If you're afraid of facts or you're not emotionally mature enough to hear a contrary opinion, then you have the right to put me on ignore, but you don't have the right to expect me to be silent. And again, whenever I become the topic of conversation, please remember that I'm not the one who is behaving abnormally. For review: WeeZuhl is a powerless solitary shareholder, Mikah is the parasite company sucking our wealth. Please don't get them confused. The many members of the Hakim Fan Club can continue to meet here for their daily admirations, but if you're terrified of turds in the punchbowl, then don't drink the punch.
So Yankee001, I am the quintessential true long. I'm entirely focused on my payoff at the buyout. You can whine all you want about routine day to day fluctuations in share price, but it's not anything I care about. I only care about getting my full share at the end. Good luck to all true longs. Repeal the Mikah Tax.
.
Repeal the Mikah Tax -- To be paid by all shareholders at buyout
1. Cost of Second Tier Suitors
2. Cost of Secret Side Deal with Hakim
3. Cost of Mikah litigation
4. Cost of remaining OTC
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
